Nephrology Perspective and Journal Articles

 
 

  • Calciphylaxis in CKD Treated With Sodium Thiosulfate Read about this case in which sodium thiosulfate was used to successfully treat a patient with CKD who developed calciphylaxis.
  • Vitamin D for COVID? We've Been Burned Before   What, if any, is the link between COVID-19 and vitamin D? Dr F. Perry Wilson digs into the data.
  • Claims About False COVID Deaths Are Reprehensible President Trump and others in the administration have claimed that physicians and hospitals are falsely attributing deaths to COVID in order to increase reimbursements. Here's why that is nonsense.
  • Stop the Benzo: It's Worth the Screaming The potential benefits of benzodiazepines among older adults are simply outweighed by the risks. But is stopping them worth the fight?
  • Albuminuria, Kidney Function, and Cancer Risk This study investigated how measurements of kidney function were independently associated with overall and site-specific cancer incidence.
  • Hypertension-Focused Medication Therapy Management How might pharmacists provide positive impact on blood pressure self-management? This study evaluated a collaborative medication therapy management pilot program for people with hypertension.
  • Medical Student Life & Education Report 2020 We surveyed current students regarding key factors affecting their education. From the COVID-19 pandemic to harassment and bias, the next generation of physicians weighs in on the challenges they face.
  • Abiraterone Acetate in High-Risk Prostate Cancer Is abiraterone acetate a safe and effective treatment choice for patients with high-risk prostate cancer?
  • KidneyWeek 2020 Read clinically focused news coverage of key developments from Kidney Week 2020
  • Heart Failure Biomarkers in COVID-19 Cardiac biomarkers may be abnormal in patients with COVID-19. Here a review of the interpretation of these markers in the context of the novel coronavirus.
  • Beta-2-Agonists and the Incidence of Parkinson Disease This study investigated the potential neuroprotective effect of beta-2-agonists on the incidence of Parkinson's disease in a large population-based cohort study.
  • COVID-19 Management Dr. David Cennimo, assistant professor of medicine and pediatrics in infectious diseases and associate program director of the Rutgers NJMS medicine-pediatrics residency, discusses COVID-19 management in the hospital setting, lingering complications after resolution of infection, the unique challenges we face this flu season, and the distribution of a potential SARS-CoV-2 vaccine.
  • 'It Was Like Seeing a Disparity Built Right Before My Eyes' "When you're Black and you're a doctor, there is no badge big enough to make people realize you're a doctor."
  • Abnormal Liver Function Tests and Outcomes in COVID-19 This study found that abnormal liver function tests are common in hospitalized patients with COVID-19 and strongly predict a worse clinical course of the disease
  • An Escape From Diabetes Can diabetes be cured? This commentary discusses new research on pharmaceutical strategies that may effectively induce diabetes remission.
  • COVID-19 and Diabetes This report provides insight into the clinical course of COVID-19 in patients with diabetes. What have we learned?
  • Renal Cell Carcinoma Highlights From ESMO 2020   Dr Robert Motzer reviews key studies on renal cell carcinoma presented at the 2020 ESMO Virtual Congress, including phase 3 trial results showing benefit from combination therapies in advanced RCC.
  • ESC 2020 Highlights: Treatment Strategies & the Virtual Experience   The first randomized trial on stopping ACE inhibitors and ARBs in patients with COVID-19, and a comparison of rhythm vs rate control in AF are among the strategies tested in trials presented at ESC 2020.
  • Polypharmacy and Potential Drug-Drug Interactions for HIV Are you aware of the types of concurrent medications commonly prescribed to HIV patients and the potential drug-drug interactions?
  • Chronic Liver Disease and Outcomes of Patients With COVID-19 This study found that one in five patients hospitalized with COVID-19 had underlying chronic liver disease. What was the impact of CLD on COVID-19 symptoms and outcomes?